Tazarotene is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Taro Pharmaceuticals U.s.a., Inc.. The primary component is Tazarotene.
Product ID | 51672-1374_e8ef4870-6351-4567-adb4-b8a8778183ad |
NDC | 51672-1374 |
Product Type | Human Prescription Drug |
Proprietary Name | Tazarotene |
Generic Name | Tazarotene |
Dosage Form | Cream |
Route of Administration | TOPICAL |
Marketing Start Date | 2017-04-03 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA208258 |
Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
Substance Name | TAZAROTENE |
Active Ingredient Strength | 1 mg/g |
Pharm Classes | Retinoid [EPC],Retinoids [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2017-04-03 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA208258 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2017-04-03 |
Ingredient | Strength |
---|---|
TAZAROTENE | 1 mg/g |
SPL SET ID: | 34d79c31-1568-4797-a4f5-31200c7788db |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0168-0454 | TAZAROTENE | tazarotene |
0713-0670 | Tazarotene | Tazarotene |
0713-0764 | Tazarotene | Tazarotene |
0713-0804 | TAZAROTENE | tazarotene |
0713-0805 | TAZAROTENE | tazarotene |
51672-1373 | Tazarotene | Tazarotene |
51672-1374 | Tazarotene | Tazarotene |
60758-556 | Tazarotene | Tazarotene |
60758-561 | Tazarotene | Tazarotene |
68308-685 | tazarotene | tazarotene |
68308-745 | Tazarotene | TAZAROTENE |
0187-2098 | Arazlo | tazarotene |
0023-9236 | AVAGE | tazarotene |
51862-295 | FABIOR | tazarotene |
0168-0455 | Tazarotene Cream | tazarotene |
0023-0042 | TAZORAC | tazarotene |
0023-8335 | TAZORAC | tazarotene |
0023-9155 | TAZORAC | tazarotene |
0023-9156 | TAZORAC | tazarotene |
16110-042 | Tazorac | tazarotene |
16110-833 | Tazorac | tazarotene |
16110-915 | TAZORAC | tazarotene |
16110-916 | TAZORAC | tazarotene |